Elevated intraocular pressure (IOP) is the major risk factor for glaucoma. In the clinic, the response to elevated pressure and thus the risk for development of glaucoma differs among individuals. We took advantage of our ability to subject postmortem human eyes from the same individual to physiological and elevated pressure in a perfused outflow model and compared individual patterns of gene expression under pressure. The architecture of the trabecular meshwork, tissue responsible for the maintenance of IOP, was conserved. We performed two sets of experiments. The first set (n ϭ 5, 10 eyes) used Affymetrix GeneChips, identified the 20 most pressure-altered genes in each individual, and compared their pressure response in the other four. The second set (n ϭ 5, 10 eyes) selected 21 relevant trabecular meshwork genes and examined, by real-time TaqMan-PCR, the rank of their abundance and of their pressure differential expression in each individual. The majority of the up-and downregulated top-changers of each individual showed an individual response trend. Few genes were general responders. Individual responders included STATH, FBN2, TF, OGN, IL6, IGF1, CRYAB, and ELAM1 (marker for glaucoma). General responders included MMP1, MMP10, CXCL2, and PDPN. In addition, we found that although the relative abundance of selected genes was very similar among nonstressed individuals, the response to pressure of those same genes had a marked individual component. Our results offer the first molecular insight on the variation of the individual response to IOP observed in the clinical setting. individual response; trabecular meshwork; microarrays THE INTRAOCULAR PRESSURE (IOP) of the human eye under normal physiological conditions is 10 -22 mmHg (mean 16 Ϯ 6 mmHg) (58), while the pressure of the episcleral veins, site of the aqueous humor drainage outside the eye, is 8 -9 mmHg (24). This pressure differential is essential to maintain the ocular globe inflated. Increased changes in IOP create a mechanical stress situation that, in a not well understood manner, is transmitted to the back of the eye and exerts damage to the retinal ganglion cells (RGC) and to their axons (optic nerve). Death of RGCs impedes transmission of the visual signal to the brain and results in progressive loss of visual field and irreversible blindness. The resulting disease is glaucoma, the second leading cause of blindness worldwide (49). Elevated IOP is the major risk factor for glaucoma, and lowering IOP is the only currently available treatment for all types of glaucoma.
THE INTRAOCULAR PRESSURE (IOP) of the human eye under normal physiological conditions is 10 -22 mmHg (mean 16 Ϯ 6 mmHg) (58) , while the pressure of the episcleral veins, site of the aqueous humor drainage outside the eye, is 8 -9 mmHg (24) . This pressure differential is essential to maintain the ocular globe inflated. Increased changes in IOP create a mechanical stress situation that, in a not well understood manner, is transmitted to the back of the eye and exerts damage to the retinal ganglion cells (RGC) and to their axons (optic nerve). Death of RGCs impedes transmission of the visual signal to the brain and results in progressive loss of visual field and irreversible blindness. The resulting disease is glaucoma, the second leading cause of blindness worldwide (49) . Elevated IOP is the major risk factor for glaucoma, and lowering IOP is the only currently available treatment for all types of glaucoma.
The tissue responsible for maintaining the differential pressure in the eye is the outflow tissue, formed by the trabecular meshwork and the single cell layer lining the Schlemm's canal. This outflow tissue (from now on referred to as the "trabecular meshwork") is avascular, it is localized at the angle formed by the cornea and the iris, and, in humans, is the main route for the outflow of aqueous humor (9) . The trabecular meshwork consists of layers with different cell types (uveal, corneoscleral, juxtacanalicular, inner wall of the Schlemm's canal), and it is embedded in a spongiform-like extracellular matrix (ECM). All components of the outflow tissue, in particular the composition and quality of the ECM, play an important role in establishing the resistance required to attain physiological pressure. Expression of the trabecular meshwork genes is affected by factors present in the aqueous humor and especially by the mechanical forces generated by the continuous flow of aqueous humor under pressure.
During the past few years, in our laboratory we have been interested in studying the differential expression of the human trabecular meshwork genes under conditions of elevated IOP.
To obtain differential gene expression results that could be relevant to the molecular understanding of the effects of the elevated IOP in humans, a number of key factors need to be taken into account. First, the appropriate mechanical stimulation has to be applied. The mechanical forces exerted by flow of the aqueous humor in vivo are not present in traditional cell cultures, where the bottom of the dish precludes the presence of the pressure drop; thus to best mimic the physiological pressure response of the trabecular meshwork, the full architecture of the tissue needs to be preserved. Second, it is well established in the field that the aqueous humor outflow pathways of lower vertebrates differ significantly from that of humans (52) , to the point that drugs known to lower IOP in such animals do not have the same effect in the clinic. It is therefore important to use human material. The third key issue when studying gene expression in human samples involves individual variability. Several studies have shown that not all eyes respond similarly to factors affecting IOP (56, 58) . The distribution of physiological IOP fits a wide bell-shape curve for pressures up to 21 mmHg, after which a skewness to the right occurs (21) . IOP is affected by numerous factors including age (23, 57) , geographic location (21) , and specially, hereditary influences (5, 39) . In addition to pressure, a variety of other risk factors have been associated with glaucoma, like cardiovascular (30) and autoimmune diseases (53) . Importantly, in every case, glaucoma patients with all range of pressures do benefit by treatment with drugs that lower IOP.
Taken all above parameters into account, here we have performed a study addressing, for the first time, the molecular individual response to ocular pressure in the human eye. In a systematic manner, we addressed each potential drawback of the standard cellular approaches. We used perfused anterior segment organ cultures from human eyes of postmortem do-nors, treated one eye of each pair, and compared expression of the two eyes from the same individual (same genetic background). Then, we analyzed the response of each individual separately, rather than pooling all treated and untreated human samples.
In our first set of experiments, we searched the entire human transcriptome by the use of oligonucleotide GeneChips. In the second set, we studied the kinetics of differential expression (TaqMan-PCR) of a set of 21 rationally selected genes. We found that while the relative abundance of genes was very similar among nonstressed individuals, the response to the pressure insult had a marked individual component. A number of genes responded to pressure in most individuals (named general responders) while others responded only in a few (named individual responders). Among general responders we identified genes associated with ECM deposition and formation of the elastin network, as well as genes involved with a calcification process and commitment of mesenchymal cells to osteoblasts. With a few exceptions, the direction of response of these genes seemed to suggest an outcome which was representative of a compensatory mechanism to facilitate outflow facility. Among the individual responders, the direction appeared to be equally representative of both protective and detrimental mechanisms to the outflow facility's function. Interestingly, ELAM1, a secreted glycoprotein that has been found to be the first marker of glaucoma (71) , was sharply downregulated in only one sample, a possible suggestion of a protection to glaucoma in such individual.
This study provides the first glimpse on the regulation of IOP in human subjects and would lead to the understanding of the variability of response to pressure in the clinic.
MATERIAL AND METHODS
Perfused human anterior segment organ cultures. Thirteen pairs of normal, nonglaucomatous human eyes from donors ages 61-84 yr were obtained from national Eye Banks (Lions Eye Bank, OR; National Disease Research Interchange, PA; North Carolina Eye Bank, NC) following signed consent of the patients' families. All procedures were in accordance with the Tenets of the Declaration of Helsinki. Whole eye globes within 8 -40 h of death were dissected at the equator, cleaned away from vitreous, iris, and lens, and then mounted on the custom-made perfusion chambers as described previously (14, 15, 35) (Fig. 1) . These anterior segments were perfused through one of the chamber's two cannulas with serum-free high glucose DMEM (Invitrogen-GIBCO, Carlsbad, CA) with antibiotics, using a Harvard microinfusion pump (Harvard Bioscience, South Natick, MA). IOP was monitored with a pressure transducer connected to the second cannula and recorded via an automated computer system. Pumps were controlled by a custom-made computer program (Infusion Pump Control Program, University of North Carolina Chemistry Department Electronic Design Facility) that allows the perfusion of each eye to be conducted at either constant flow while recording changes in pressure or at constant pressure while recording changes in perfusion flow. Anterior segments were maintained at 37°C and 5% CO 2 and perfused for 24 h to establish a stable baseline (steady pressure recordings for at least 10 h). For baseline, perfusion was performed at constant flow to emulate the flow rate of the human aqueous humor and to evaluate the pressure parameters of the eye at close to physiological conditions. The flow to each eye was maintained constant, and the initial flow rates for all the eyes of the study were between 2 and 4.5 l/min. Outflow facility (C), also defined as the inverse of the resistance (R), was calculated as the rate of the flow (F) divided by pressure (P) (Goldman's equation) and measured in l ⅐ min Ϫ1 ⅐ mmHg Ϫ1 . Flow and pressure parameters were continuously captured by the system, and the software was set to record single points every 30 min. Baseline facility (C 0) was calculated from the average of three values obtained from pressure readings recorded at 30 min intervals just before treatments. For these differential expression experiments, facility baseline inclusion was set between 0.05 and 0.7 l ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , which has slightly higher ends than those used for determination of effect of drugs and insults on outflow facility (15, 70) .
For the elevated pressure treatment, after obtaining a stable baseline for 24 h, we raised the pressure of one eye in each pair to obtain a ⌬P between 30 and 47 mmHg over baseline values for periods of 7 days (6 pairs) or 3 days (6 pairs), respectively. The contralateral eye of each pair was maintained at baseline values (ϳ15 mmHg), serving as a control. In one pair, tonometer pressure measurements were performed of the eye while in the chambers and found to correlate with pressures being read by the transducers. In one pair [individual (ind.) #13] stable baseline was obtained for 4 h. Ten of the thirteen eye pairs of the study (inds. #3-#11 and #13) were perfused at constant pressure and three (inds. #1, #2, and #12) were perfused at constant flow. At all times, the flow rate of the perfusion media of all eyes was Ͼ2 l/min, which enhances cell survival (34) . At the end of the experiment, anterior segments were immediately immersed in RNAlater (Ambion, Austin, TX) and stored at 4°C for subsequent dissection of the trabecular meshwork and RNA extraction. One eye pair (ind. #13) was fixed and processed for immunohistochemistry (see below). A detailed morphological study of human trabecular meshworks subjected to the same condition and showing good cellular viability was published earlier by our laboratory (15) . In addition here, we assessed cell viability at the end of the experiment by the examining the quality of the extracted RNA (see below).
RNA extraction. Under a dissecting microscope, human trabecular meshworks were excised from 1 wk RNAlater-immersed anterior segments by making incisions both anterior and posterior to meshwork and then removing the tissue with forceps. Each isolated trabecular meshwork was homogenized in one sterile glass microtissue grinder (Kimble-Kontes, Vineland, NJ) with 350 l of guanidine thiocyanate buffer (RLT; QIAGEN, Valencia, CA). RNA extraction was performed by loading the homogenized solution onto a QIAshredder column (QIAGEN) and continued by the use of the RNeasy Mini kit with on-column RNase-free DNase digestion according to manufacturer's recommendations (QIAGEN). Total RNA recoveries averaged 0.63 Ϯ 0.06 g per single trabecular meshwork. Total RNA was concentrated by SpeedVac (Thermo-Savant, Waltham, MA) and quality assessed by measuring the size distribution on an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA). Only samples which RNA's chromatographic profile showed distinctive 28S and 18S peaks at a ratio of 2:1 were used in the study.
RNA microarrays hybridization. The RNAs from the eyes of five individuals were prepared for hybridization to Human Genome U95Av2 (n ϭ 4) or U133Plus2.0 (n ϭ 8) GeneChips (Affymetrix, Santa Clara, CA) at the University of North Carolina (UNC) Functional Genomics Core Facility. These oligonucleotide microarrays contain, respectively, ϳ12,625 and 54,678 probe sets, representing ϳ10,800 and 39,500 well-established human genes. The level of transcription of each gene represented on these chips is measured using either the 16-or 11-nucleotide sequences that comprise each probe set. For the hybridization, total RNA (ϳ0.7 g) was reverse transcribed into cDNA, amplified once by in vitro transcription, reverse transcribed into cDNA, and then used to generate biotinylated cRNA with a MessageAmp II-Biotin Enhanced Single Round aRNA Amplification Kit (Ambion). The cRNA was then fragmented in fragmentation buffer at 94°C for 35 min before the chip hybridization. We then added 15 g of amplified fragmented cRNA to a hybridization cocktail (0.05 g/l fragmented cRNA, 50 pM control oligonucleotide B2, BioB, BioC, BioD, and cre hybridization controls, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml acetylated BSA, 100 mM MES, 1 M [Na ϩ ], 20 mM EDTA, 0.01% Tween 20). We used 10 g of cRNA for hybridization. Arrays were hybridized for 16 h at 45°C in the GeneChip Hybridization Oven 640. The arrays were washed and stained with R-phycoerythrin streptavidin in the GeneChip Fluidics Station 450. Arrays were scanned with the GeneChip Scanner 3000 7G Plus. Affymetrix GeneChip Microarray Suite 5.0 software was used for basic analysis. Sample quality was assessed by examination of 3Ј to 5Ј intensity ratios of certain genes. Subsequent analysis of differential expression between the two eyes from a single individual was performed with Microarray Suite 5.0 and Excel. Only genes whose probe sets comparisons showed differential expression values with P Յ 0.0001 were considered.
GeneSpring analyses. Row data CEL files from Affymetrix were imported into GeneSpring GX Expression Analysis software, version 7.3.1 (Agilent Technologies). Data were analyzed in two different ways. For analysis of global expression changes between the two eyes from the same individual, data from a set of two chips (untreated control and high pressure treatment) were preprocessed through the robust multichip average (RMA) and normalized using the data transformation and 50th percentile normalization algorithms. The data transformation normalization sets any measurements less than a specified cutoff value (default 0.01) to the cutoff value; it ensures that no negative values are loaded. The 50th percentile normalization step divides the expression values of each chip by the median of all expression values; it ensures that the expression values for each chip can be compared.
The normalized data were subsequently filtered on expression level using a minimum signal value of 50 to eliminate genes expressed at lower levels in at least one out of two conditions. To identify the top-changers on each individual, data were then filtered on fold change to select genes that exhibited at least a 1.5-fold increase or decrease in human trabecular meshwork exposed to elevated pressure. Approximately, the 20 top-changers of each condition per each individual were selected. Gene ontologies (GO) were obtained from the GO SLIMS lists available in the GeneSpring software, which contain subsets of the terms in the whole GO. Gene symbols were used to identify additional gene functions and location parameters by the use of the Stanford Source (http://source.stanford.edu) and the GenAtlas (http://www.dsi.univ-paris5.fr/genatlas/) databases. Genes without a known symbol, such as images clones or transcribed locus were not considered.
Conversion of the U95Av2 annotations to U133Plus2.0 was conducted by the use of the "pick.pl" program generously provided by Dr. Chris Fan (Lineberger Comprehensive Center, UNC at Chapel Hill). Overlapping gene lists were obtained with the use of the Venn diagram analyses in GeneSpring.
Trabecular meshwork-focused PCR arrays. To analyze the expression of a focused panel of genes with the reliability provided by the kinetic's reaction of a real-time PCR, we custom-designed a TaqMan-PCR array. A panel of trabecular meshwork genes was selected following the criteria explained in RESULTS. Fluorescently labeled TaqMan probes/primers set for these genes were purchased from the Applied Biosystems TaqMan Gene Expression collection (http:// www.allgenes.com) and the list is shown in Table 1 . Each selected gene was amplified in triplicate. Because of the limitations imposed by the amount of RNA obtained from the trabecular meshwork of a single human eye, we optimized the reverse-transcription and amplification reactions to analyze the maximum number of genes while maintaining a CT (cycle at threshold) value within the exponential range. For the reverse-transcription (RT), the RNA from one entire trabecular meshwork was lyophilized and converted to cDNA using the High Capacity cDNA kit (Applied Biosystems) following manu-facturer's recommended conditions but at half the volume (25 l). After the RT, 21 l were first diluted 3ϫ in RT buffer and then added to 1,134 l of TaqMan Universal PCR Master mix no AmpErase UNG (Applied Biosystems) (total volume 1,197 l). After being carefully mixed, 19 l of this RT/Taq buffer reaction mix were dispensed into each of 63 wells of a 96-optical grade plate (ABI). A gene pattern was drawn on the plate, and triplicates of 1 l aliquots from each gene probe were added to each well. The same gene pattern was maintained for the 10 plates studied. As an endogenous control, we used 18S rRNA. Because of the high abundance of the 18S rRNA, and to get a linear amplification, RT reactions from control and experimental samples were diluted 10 4 times prior to their hybridization to the 18S TaqMan probe. Under these conditions, the CT values of all the amplified genes in control and treated samples were approximately between 17 and 35.
Each individual plate was run on an Applied Biosystems 7500 Real-Time PCR System and analyzed by 7500 System SDS software (Applied Biosystems). For each individual, reactions from the two eyes (control and elevated pressure treated) were run in two different 96-well plates and results from each plate were stored in the ABI instrument software. Two plates from the eye pair of the same individual (control and treated) were then analyzed together for the calculation of differential gene expression (fold changes). This analysis recalculates threshold C T values and normalizes the two plates. Commercially available PCR array plates to amplify a set of custommade and/or functionally related genes were considered and rejected because of their inability to include replicate measurements.
Differential expression and relative abundance of the trabecular meshwork-focused genes. Relative quantification (RQ) values between treated and untreated samples were calculated by the formula 2 Ϫ⌬⌬CT , where CT is the cycle at threshold (automatic measurement), ⌬CT is CT of the assayed gene minus CT of the endogenous control (18S rRNA), and ⌬⌬CT is the ⌬CT of the normalized assayed gene in the treated sample minus the ⌬CT of the same gene in the untreated one (calibrator). RQ values Ͼ1 correspond to increased fold changes. RQ values Ͻ1 correspond to a fraction of the gene expression and were converted to decreased fold changes by the formula Ϫ1/2 Ϫ⌬⌬CT . That is, an RQ of 4 corresponds to an increased expression of fourfold (ϩ4), while an RQ of 0.25 corresponds to a reduction of expression of fourfold (Ϫ4). Standard deviation (SD) of the ⌬⌬C T is calculated by the ABI software using the SDs of the ⌬C Ts of control and treated samples (see below and http://docs.appliedbiosystems.com/pebiodocs/04371095.pdf). Fold changes calculated using this ⌬⌬C T method are then expressed as a range (minimum and maximum), which is the result of incorporating the SD of the ⌬⌬C T value into the fold change calculation (2 Ϫ⌬⌬CT ϩ SD and 2 Ϫ⌬⌬CT Ϫ SD ). Fold change range values are represented in the figures as asymmetric SD bars.
To determine the relative abundance of each gene under control conditions, the expression of the target gene was compared with that of its own endogenous 18S rRNA using the average ⌬C T values from the replicate measurements (mean CT of the assayed gene minus mean CT of its endogenous 18S rRNA). The SD of the ⌬CT was calculated using the formula s ϭ (s1 2 ϩ s2 2 ) 1/2 where s1 and s2 are the SD for each mean CT value from the target gene and its 18S, respectively. The fold change value of the target gene over 18S expression was then calculated using the 2 Ϫ⌬CT formula, and the range of maximum and minimum values were calculated as above (2 Ϫ⌬CT ϩ s and 2
Ϫ⌬CT Ϫ s ). Immunohistochemistry. Eyes from pair #13 were fixed in the chambers at the experimental pressures with 4% paraformaldehyde-PBS at room temperature overnight. Specimens were then consecutively washed in 10% sucrose (6 h) and 30% sucrose (overnight) and frozen in Tissue-Tek OCT (Sakura Finetek, Torrance, CA) in liquid nitrogen. Meridional 10 m cryosections from opposite quadrants of each eye (HP and CP) were mounted on Superfrost/Premium microscope slides (Thermo Fisher, Waltham, MA) and saved at Ϫ80°C. For the Podoplanin detection, sections were allowed to dry at room temperature for 30 min, blocked with 10% goat serum, 0.3% Triton X-100 in PBS for 1 h, and incubated overnight with a mouse monoclonal anti-human Podoplanin antibody (1:500) (Bender Medsystems, Burlingame, CA) at 4°C. Sections were then incubated with a goat anti-mouse Alexa Fluor 555 secondary antibody (1:200, Invitrogen) at room temperature for 2 h. All antibody solutions were made in blocking buffer and washes with PBS were performed between all incubation steps (3ϫ, 5 min each). Sections were mounted with coverslips and Fluoromount G (Southern Biotechnology Associates, Birmingham, AL) and sealed with clear enamel. Fluorescence imaging was conducted with an Olympus IX71 fluorescence microscope and images were captured using an Olympus DP70 camera and accompanying software using the same exposure for all slides. Digital images were arranged with image analysis software (Photoshop CS; Adobe, Mountain View, CA). Negative controls were run in parallel but were incubated in blocking buffer in place of the primary antibody.
RESULTS

Individual parameters and elevated IOP insult values.
The characteristics of all the individuals used in the study are shown in Table 2 . The sample is random, and none of the individuals was known to have glaucoma at the time of death. All individuals (8 males and 5 females) were Ͼ60 yr of age. All but one individual were Caucasians.
The anterior segments from the paired eyes of each individual were perfused simultaneously as indicated in MATERIAL AND METHODS. Because of unavailability of the constant pressure software at the time of inds. #1 and #2 perfusion, these two pairs of eyes were perfused at constant flow. Eyes from inds. #3-#11 and #13 were perfused at constant pressure and eye #12 was chosen to perfuse at constant flow.
The effect of postmortem time on the viability of the tissue was demonstrated by comparing morphology and gene expression of two eyes from the same pair perfused at 8 h and 32 h postmortem, respectively (ind. #12, not shown). Figure 1 shows a diagram of the system (Fig. 1A ) along with the pressure elevation trace from a representative 3 days sustained pressure individual (Fig. 1B) , and a diagram of the location of the human trabecular meshwork together with an electron microscope micrograph. The average outflow facility (C) value at baseline of the eye pairs of the study was 0.22 Ϯ 0.03 l ⅐min Ϫ1 ⅐mmHg Ϫ1 (n ϭ 26). At the end of the experiment, the average ⌬P from baseline was 35.3 Ϯ 1.4 mmHg on the eyes receiving the 7 days insult (n ϭ 6 pairs), while that of the contralateral eyes of the same set experienced an average ⌬P of Ϫ1.9 Ϯ 2.0 mmHg. Those eyes treated with elevated IOP for 3 days (n ϭ 6 pairs) had an average ⌬P from baseline of 36.9 Ϯ 2.5 mmHg, while the pressure increase of their corresponding contralaterals during the duration of the experiment was ⌬P 2.0 Ϯ 1.7 mmHg.
Genes most altered in perfused human intact trabecular meshwork after a 7-day elevated IOP insult in five different individuals. Search for individual and general response. Because of the unique situation of an eye pair, where a given treatment can be compared with the nontreated tissue in the genetically identical individual and because of a well-known occurrence of individual responses to IOP in the clinic (56), we performed microarray analyses on each individual separately (n ϭ 5, 10 chips). Two of the individuals (inds. #1 and #2) were studied using the U95Av2 chips, and the remaining three were analyzed with U133Plus2.0 chips (Affymetrix).
Using the algorithms of Microarray Suite 5 software (Affymetrix) to determine Present or Absent in the chips, we found that overall the percentage of genes assigned as Present was very similar between the high pressure treated (HP) (46.8 Ϯ 1.5%) and control pressure (CP) eyes (46.1 Ϯ 2.1%) in all individuals. The percentage of Absent genes was slightly higher, but also similar between HP (51.2 Ϯ 1.6%) and CP eyes (52.1 Ϯ 2.1%) ( Table 3 ). On the other hand, except for ind. #4, the subset of genes that were turned on by elevated pressure (Absent to Present) was larger than the subset of those which were turned off by the insult (Present to Absent) (Present signal Ն50, P Յ 0.04). The percentage of genes on these subsets ranged from 1.1 to 3.5% and was quite similar in all individuals (Table 4) . Using the RMA processing and the algorithms of the GeneSpring software, we found that the total percentage of genes altered (up-and downregulated) by pressure Ͼ1.5-fold was quite different between individuals. While inds. #1 and #5 were almost identical, with close to 2.5% of the genes altered Ն1.5-fold, ind. #2 had twice as many genes in the upregulated subset, ind. #3 had six times more in the upregulated subset, and ind. #4 had the same number up and down, but both in much lower percentage (0.7% each) ( Table 5 ). Tables showing  the top 100 differential genes in each individual are included in  the supplement (Supplemental Tables S1-S5   1 ). Together, these analyses indicate that overall, the levels of gene expression changes that occur with elevated pressure are quite specific, do not amount to huge turnovers, and vary between individuals.
To investigate whether there was a different individual response at the gene level, we analyzed the pressure regulation of the most pressure-altered genes of each of the five eye pairs (200 genes). We used the same RMA processing and converted the U95Av2 gene lists to the U133Plus2.0 platform. We selected the 20 most upregulated and the 20 most downregulated genes in each individual and searched the pressure response of these top-changers in the other four (filter of Ն or Յ1.5-fold in gene expression) (Figs. 3 and 4) .
To determine the presence of common genes, that is, of genes that responded to pressure in all individuals, we additionally compared not only the 20 top-changers, but the lists of genes altered 1.5-fold in each individual. We then searched for overlapping genes in all five individuals (see below, Fig. 5) .
Overall heat maps of the fold changes of shared genes on the U133Plus2 platform. To gain a first insight on the nature and extent of the personal response to pressure, we selected shared genes from the individuals studied on the U133Plus2 platform, and analyzed their overall expression using heat maps (Fig. 2) . Each row of the map represents the pressure response of a single gene in the three individuals (inds. #3, #4, and #5), expressed in fold change expression of the HP eye over that of the paired CP. Each column represents the number of selected genes in one individual. All heat maps shown in Fig. 2 reflect the individual nature of the response to pressure. Figure 2A , which analyzes those genes whose expression was altered in at least two individuals (542 genes, see below), has very few rows showing a uniform color. This is an indication that those genes, although responding, were doing so in an individual manner. The individual response was better observed when the same analysis was repeated, but instead using genes whose expression was altered in all three individuals (50 genes, see below) (Fig. 2B) . The heat map of this smaller list shows that very few genes, such metallopeptidase 1 (MMP1) and matrix metallopeptidase 10/stromelysin 2 (MMP10) (5th and 7th row from the bottom), are responding in a general manner.
Heat maps on Fig. 2 , C-E, compare gene lists of upregulated genes shared in two of the three individuals, separately. These maps, containing either 35 genes (upregulated in inds. #3 and #4, Fig. 2C ), 46 genes (upregulated in inds. #4 and #5, Fig.  2D ), and 69 genes (upregulated in inds. #3 and #5, Fig. 2E ), show that although most genes are altered in the third individual, very few are also upregulated. In addition, one to three genes in each map did not pass the minimal expression criteria (gray color), indicating they were not event expressed (absent signal). These findings further reinforce a personal and individualistic response to elevated IOP in the human trabecular meshwork.
Individual trend on the most pressure-upregulated genes. Out of the 100 top up-changers (20 from each individual), we found that a high proportion of genes showed a marked individual response (Fig. 3) . Some of the genes were upregulated in just two of the five individuals and some were upregulated in only one of the five. Among them, there were a number of genes known or suspected to be significant for trabecular meshwork's function such as insulin-like growth factor 1 (IGF1), aldose reductase (AKR1B10), matrix GLA protein 1 The online version of this article contains supplemental material. (MGP), substance P precursor (TAC1), fibulin 5 (FBLN5), fibrillin (FBN1), secreted frizzled-related protein 1 (SFRP1), prostacyclin (PTGIS), and lysyl oxidase (LOX). Thus, the inhibitor of calcification MGP is downregulated in glaucomatous tissues (75) , and SFRP1 is increased in trabecular meshwork cells from glaucomatous patients (72) . Two particular genes, osteoglycin (OGN) and transferrin (TF), were present twice in the top up-changers list of inds. #3 and #4, respectively, but they were not changed in any of the others, a strong indication that they are individual responders and that such individual response appears to be real. OGN, a gene associated with commitment to the osteogenic phenotype (6), is upregulated in the trabecular meshwork by transforming growth factor (TGF)-␤2 (78), a growth factor elevated in the aqueous humor of glaucoma patients. Transferrin, a protector of oxidative damage, has also been reported in human and bovine trabecular meshwork (7, 55) .
Other individual responder genes which have not yet been reported in the trabecular meshwork include phosphoenolpyruvate carboxykinase 1 (PCK1), adrenergic ␤1 receptor (ADRB1), chemokine (C-C motif) ligand 14 (CCL14), and protocadherin 17 (PCDH17). The higher proportion of fully individual responder genes occurred in ind. #5, who had 9 genes out of his/her 20 top-changers singly upregulated (Fig. 3) . Fig. 1 ) was treated with elevated pressure for 7 days, while its contralateral (OD, Fig. 1 ) was maintained at physiological pressure. For each individual, the expression of trabecular meshwork genes of the treated eye was compared with that of its paired contralateral using Affymetrix GeneChips. The response to pressure of the 20 most upregulated genes from each individual was searched in the other 4 at a cutoff fold change value of Ն or Յ1.5. A: inds. #1, #2, and #3. B: inds. #4 and #5. Pink, upregulated genes; blue, downregulated genes; yellow, no change (NC); green, gene probe no present in the chip (np). *Genes with Ͼ1 probe set at the 1.5-fold cutoff; **genes with Ͼ1 probe set on the 20 most upregulated list; bold, genes present in the 20 top upregulated lists in Ͼ1 individual. General and individual responders are easily identified by following the pink-blue rows (general, rows with 3-5 blocks; individual, rows with 1 and 2 blocks).
Results from Fig. 3 further showed that the fold change values of the top up-changers, for the five individuals were between 8.8-and 4.1-fold. These relative small values are in contrast with those seen for the trabecular meshwork subjected to other glaucomatous conditions such as dexamethasone (DEX) and TGF-␤2, an indication that pressure is not producing drastic changes but acts through a more subtle modulation of gene expression.
Individual trend among the most pressure-downregulated genes. Results from Fig. 4 showed that out of the 100 top down-changers (20 from each individual), there was also a high number of genes with an individual response to pressure. As above, some were affected in just two of the five individuals, and quite a few were downregulated only in one.
Among those responding in two individuals we found dual specific phosphatase 1 (DUSP1), transgelin (smooth muscle 22) (TAGLN), basic fibroblast growth factor 2 (FGF2), and chondroitin sulfate proteoglycan 2 (versican) (VCAN), all relevant to trabecular meshwork function. The dual-specific phosphatases (DUSP1 and DUSP2) are from a family of negative regulators of the MAP kinase pathway genes, important for cell proliferation and well studied in the trabecular meshwork (2, 36) . TAGLN encodes a protein that regulates the actin cytoskeleton and is altered by some other glaucomatous conditions (11, 54) . Growth factor FGF2 has been detected in HTM cells and aqueous humor (10) , where it has been suggested to act in cell proliferation (65) . And VCAN, which encodes a chondroitin sulfate proteoglycan, is a key component of the trabecular meshwork's ECM also altered in other conditions associated with glaucoma (37, 74) .
Inds. #2 and #4 had the highest number of individual responders (5 and 9 out of 20, respectively). Among those with potentially relevant trabecular meshwork functions were ␥2-actin (ACTG2), statherin (STATH), cadherin 19 (CDH19), fibrillin 2 (FBN2), and endothelial adhesion molecule 1 (ELAM1). STATH encodes an ECM protein that regulates calcium phosphate-binding and bone mineralization (76) , and cadherins are calcium-dependent cell adhesion proteins. Both might be essential to maintain the trabecular meshwork integrity needed to modulate the aqueous outflow resistance. FBN2 is a structural glycoprotein that contributes to elastin assembly in the ECM of the trabecular meshwork. Most important, Fig. 1 ) was treated with elevated pressure for 7 days, while its contralateral (OD, Fig. 1 ) was maintained at physiological pressure. For each individual, the expression of trabecular meshwork genes of the treated eye was compared with that of its paired contralateral using Affymetrix GeneChips. The response to pressure of the 20 most upregulated genes from each individual was searched in the other 4 at a cutoff fold change value of Ն or Յ1.5. A: inds. #1, #2, and #3. B: inds. #4 and #5. Pink, upregulated genes; blue, downregulated genes; yellow, NC; green, np. *Genes with Ͼ1 probe set at the 1.5-fold cutoff; **genes with Ͼ1 probe set on the 20 most upregulated list; bold, genes present in the 20 top upregulated lists in Ͼ1 individual. General and individual responders are easily identified by following the pink-blue rows (general, rows with 3 to 4 blocks; individual, rows with 1 and 2 blocks).
ELAM1, whose encoded adhesion protein is increased in glaucomatous human trabecular meshwork tissues and cells, is considered the first molecular marker specific for glaucoma (71) . The marked individual response of ELAM1 was also seen in the trabecular meshwork-focused TaqMan arrays (see below). Figs. 3 and 4 , we observed that of the 200 top-changers (20 most up and 20 most downregulated per individual), only two genes were altered in all five individuals. These two genes, MMP10 and MMP1, are key contributors to the remodeling of the trabecular meshwork's ECM and to the regulation of aqueous humor outflow (1, 16, 43) . In particular, MMP1 (interstitial collagenase) has been extensively associated with lowering IOP (3, 4, 26, 27) ; its expression is downregulated by DEX (54) and by overexpression of a nonsecreted myocilin mutant (13) , while it is upregulated by latanoprost (31) and overexpression of wildtype myocilin (13) .
Genes that respond to pressure in all or mostly all individuals (general response trend). When analyzing
A subset of 18 additional genes (9%) was altered in four out of the five individuals studied. Although not strictly general responders, these genes would probably have a role in the pressure regulation of most individuals. From the top up-changers (Fig. 3) this list includes angiopoietin-like 7 (ANGPTL7, CDT6), matrix metallopeptidase 12 (MMP12), secreted and transmembrane 1 (SECTM1), viperin (RSAD2), phospholipase A2 (PLA2G2A), secreted frizzled-related protein 4 (SFRP4), delta-like 1 homolog (DLK1), cell adhesion molecule 1 (CADM1), GTP-binding Ras-like protein 3 (DIRAS3), chemokines CXCL6 and CCL20, aldehyde dehydrogenase 3 (ALDH3A1), and cyclin D1 (CCND1). From the top down-changers (Fig. 4) , it includes phosphoglycerate kinase 1 (PGK1), C-type lectin 2B (CLEC2B), endothelin 3 (EDN3), calbindin (CALB2), and regulator of G protein signaling 5 (RGS5). The encoded proteins of these genes represent a combination of biological processes that are all relevant for the trabecular meshwork. For example, ANGPTL7/CDT6 is an ECM deposition protein found to be the most upregulated gene by two established glaucomatous agents (DEX and TGF-␤2) (40, 54, 78) and reported as present only in trabecular meshwork of glaucoma patients by proteomic analysis (8) . MMP12 (macrophage elastase) degrades elastin, which is an ECM scaffold protein reportedly more stained in glaucomatous histological sections To amplify our search for general responders, we generated lists of genes altered by 1.5-fold in all individuals and analyzed them using the Venn diagrams of overlapping genes. We observed that, although there was a considerable number of common genes in each of the two platforms, not much overlapping occurred between the U95Av2 (inds. #1 and #2) and the U133APlus2 gene lists (inds. #3, #4, and #5). The number of overlapping genes between inds. #1 and #2 was 277 (Fig. 5A ), amounted to 235 nonredundant. That of the genes present in inds. #3, #4, and #5 was 50 (Fig. 5B) , amounting to 45 nonredundant. Although this difference could be biological and attributed to the fact that inds. #1 and #2 were perfused at constant flow, gene expression pattern similarities with the TaqMan-focused arrays perfused at constant pressure, led us to think that the difference was probably due to different chip performance.
The conversion of the U95Av2 235 genes resulted in 537 U133Plus2.0 genes. After conversion of the U95Av2 annotations to U133Plus2.0, the number of genes common between this first platform and the total number of genes overlapping inds. #3, #4, and #5 (50 ϩ 79 ϩ 297 ϩ 116 ϭ 542 genes) was that of 43 genes (Fig. 5C ). This 43-gene list of most likely general responders included among others the trabecular meshwork relevant genes MMP1, MMP10, MMP12, ANGPTL7, and SFRP4 described above. When we created the Venn diagram with genes overlapping all five individuals, the overlapping list was just four genes (Fig. 5D) . In addition to the general responders already observed above, MMP10 and MMP1, we identified chemokine (C-X-C motif) ligand 2 (CXCL2) and podoplanin (PDPN). Of these, CXCL2 encodes for an immune response function, which is known to play a role in the trabecular meshwork. However, PDPN had not been previously reported in any trabecular meshwork study. PDPN encodes a mucin-type integral membrane glycoprotein with a potential role in tumor invasion (73) , and it represents a new candidate for pressure regulation in the human trabecular meshwork.
Enriched functions of overlapping gene lists.
To investigate potential molecular functions involved in the regulation of pressure, we search for the GO enriched functions of the overlapping gene lists in both platforms. Out of the 33 GO generic molecular function categories analyzed in the GeneSpring software, four categories were found to have P values Յ0.05 with three of them overlapping between platforms. Sorted by smallest to largest P values, the five top categories were very similar for both platforms gene lists (Fig. 6 ). Receptor binding (GO: 5102) was the most significant category in inds. #1 and #2 (P Յ 0.0000195, 12.6% genes) and the third ranked in that of inds. #3, #4, and #5 (P Յ 0.009, 14.6% genes). The peptidase activity category (GO: 8233) was the fourth most significant in both lists: #1 and #2 (P Յ 0.0128, 7.4% genes) and the #3, #4, #5 (P Յ 0.0186, 12.2% genes). This high similarity between relevant functions in both platforms is in contrast with the poor degree of overlapping seen above at the gene level and might reflect again the fact that the trabecular meshwork uses different genes with similar function to regulate intraocular pressure. Response to pressure of glaucoma-linked genes. Although no glaucoma-linked genes made the cutoff list of most altered in any of the individuals nor in some of the 1.5-fold gene lists, we searched the data files for their differential expression under the pressure insult. Myocilin (MYOC) (48, 60) , a gene specifically induced by DEX in the trabecular meshwork and whose function has not yet been determined, was altered in three out of five individuals (1.2, 2.7, Ϫ1.1, 1.0, 1.0) . Optineurin (OPTN), a gene found to be linked to predominantly normal tension glaucoma (50) , was induced in all five (1.6, 1.6, 1.3,  1.1, 1.1 ). Cytochrome P4501B1 (CYP1B1), which has been linked to primary congenital glaucoma (59) , was altered in all five individuals (1.4, 1.3, 2.0, Ϫ1.3, Ϫ1.3) . VD-40 repeat 46 (WDR6), which encodes a T cell-activating protein and is linked to primary open-angle glaucoma (POAG) (45) , was present only in the U133Plus2.0 array, where it was altered in all three individuals (1.2, Ϫ1.1, Ϫ1.1). And finally, lysyl oxidase-like 1 (LOXL1), whose similarity to LOX makes it predictable to act on elastin fibers, and whose sequence variants confer susceptibility to glaucoma (64) , was altered in four out of five individuals (1.0, 1.9, 1.7, 1.2, Ϫ1.2).
Kinetics of the individual differential expression under pressure of a panel of genes representing a molecular signature of trabecular meshwork function. We next used a different approach to study the individual effect of pressure on gene expression and developed a trabecular meshwork-focused TaqMan-PCR array. For these experiments, postmortem human donors from five individuals (inds. #6 -#10) were constant pressure-perfused in pairs and subjected to elevated pressure as indicated earlier. The pressure insult to one eye of each pair was maintained for 3 days. Given the limitation on the amounts of RNA obtained from one human trabecular meshwork, to develop these PCR arrays we first performed optimization experiments that would allow us to obtain an exponentially acceptable range for C T values in triplicate reactions of as many genes as possible (details in MATERIAL AND METHODS). For the selection of relevant genes, we conducted a rational review of those genes that over the last few years have shown an involvement in the physiology and pathophysiology of the human trabecular meshwork (references in Table 1 ). We used microarray data from our own and other investigator studies, as well as genetic linkage and confirmed reports on single genes influences on morphological, biochemical and/or physiological properties of the tissue. We selected a panel of 21 influential genes and used as endogenous control the gene encoding 18S rRNA. The TaqMan probes corresponding to the selected genes as well as their functions are shown in Table 1 . One of the purchased probes was intended to be transgelin (TAGLN), rather than transgelin 2 (TAGLN2), a gene encoding a homolog protein of unknown function. Although TAGLN2 expression has been reported to be changed by other glaucomatous agents (69), it has not been altered by elevated pressure in any of our previous pressure studies, nor in any of the Affymetrix GeneChips used here. Thus, TAGLN2 was used here as negative control.
Results of the PCR arrays from four individuals are shown in Fig. 7 (P values in Supplemental Table S6 ). A technical hitch in the endogenous control wells of the elevated pressure plate of ind. #10 precluded the inclusion of a fifth individual in the pressure evaluation. However, the control plate from this individual was good and therefore suitable for the calculation of the relative abundance study (see below). The C T values of all 21 genes were between 17.4 and 35.0. Fold change values of 17 out of 21 genes fitted under the same graph plot (Fig. 7A) , while four genes, which were altered by pressure in one of the individuals at values much higher than the others, were plotted separately (Fig. 7B) .
With the exception of TAGLN2 (negative control), all genes from this selected panel responded to pressure with fold change values significantly Ͼ1.5-fold (50% changes) in at least one of the individuals (Supplemental Table S6 ). However, the pattern of expression was very individual dependent (Fig. 7A) .
Four genes, angiopoietin-like 7 (ANGPTL7/CDT6), matrix GLA protein (MGP), myocilin (MYOC), and osteonectin (SPARC), responded significantly (Supplemental Table S6 ) in all individuals with Ͼ50% changes and were, by this approach, considered under the group of general responders. The responses of the first three were among the top-changers, while that of osteonectin was more moderate. Two other general responders genes, connective tissue growth factor (CTGF) (gene 5 in Fig. 7A ) and the secretoneurin precursor secretogranin II (SCG2) (gene 12 in Fig. 7A ) responded in three of the four individuals. The CTGF response was interesting; it was downregulated in inds. #7 and #10 but was among the most upregulated in ind. #8. CTGF is a multifunctional growth factor with an established role in ossification and bone remodeling (61) .
All remaining genes fell under the individual responders' group. The genes encoding the neuropeptide substance P precursor, tachykinin (TAC1) and SCG2 responded each in two individuals. Interestingly, the pattern of expression of the two neuropeptide-encoding genes appears to be compensatory. Inds. #6 and #10 had the expression of SCG2 (gene 12, Fig.  7A ) among their top-changer genes, while, in those individuals, the expression of TAC1 was not affected (gene 15, Fig. 7A) . Conversely, inds. #7 and #10 had a pronounced effect on TAC1 expression (top-changer), while it did not affect the expression of SCG2.
Five genes responded to pressure in only one individual and the response was moderate to low. These were apolipoprotein D (in ind. #10), chaperonin-containing TCP1 (CCT2) (in ind. #7), cochlin (COCH) (in ind. #8), pigment epithelium-derived factor (PEDF) (in ind. #8), and proteosome 26S subunit (PSMD4) (in ind. #7).
Finally, the pattern of expression of another four genes, interleukin 6 (IL6), insulin-like growth factor 1 (IGF1), Eselectin (ELAM1), and ␣B-crystallin (CRYAB), deserves special attention (Fig. 7B) . These genes were moderately induced or not induced at all in three out of the four individuals but were drastically altered in one of them. IL6 was downregulated 25-fold (Ϫ20/Ϫ33 range) in ind. #7, IGF1 was upregulated 75-fold (ϩ80/ϩ70 range) in ind. #7, ELAM1 was downregulated Ϫ11.5-fold (Ϫ9/Ϫ13 range) in ind/ #10. and CRYAB was downregulated Ϫ6.2-fold (Ϫ5.9/Ϫ6.7 range) in ind/ #7 (Fig.  7B) . This strong individual component on the expression of these genes is interesting and could help explain some of the individual differences observed in the clinic. For instance, ELAM1 expression has been associated with all glaucomatous trabecular meshwork tissues (71) . A strong individual downregulation of this gene in those patients could exert some protection from developing glaucoma from elevated pressure. Concordantly, in Fig. 4 , ELAM1 appeared on the top down- Relative abundance of the selected genes in nonstressed trabecular meshworks of different individuals. We finally investigated the expression behavior of the selected genes' panel from above under normal physiological conditions in different individuals. We wanted to know whether the relative abundance of these relevant genes under nonstressed conditions could give some insight on the functional characteristics of the human trabecular meshwork and, specially, whether it was individual dependent. For this, we analyzed the TaqMan-PCR data obtained from the control trabecular meshwork-focused array plates of inds. #6 -#10 and normalized the expression of the genes in each plate to the endogenous 18S rRNA gene. This analysis allows us to compare the relative pattern of expression of the selected genes in all nonstressed, normal individuals. Figure 8 provides a visual image of the relative abundance of these genes in each individual. Regarding relative abundance, the results revealed three groups of genes. The first group contained two genes, MGP and ␣B-crystallin, which were expressed at the highest level and were the most abundant in all individuals. In all but one individual, MGP, an inhibitor of calcification, was the highest. The levels of expression of this first group were well above, and at least 10 times higher, than those of the next group. The next rank level was composed by six genes: apolipoprotein D, connective tissue growth factor (CTGF), IL6, myocilin, superoxide dismutase, and osteonectin (SPARC). Two of these genes, CTGF and SPARC have ossification-related functions, and myocilin has been linked to glaucoma. The third-ranked group (13 genes) had considerably lower levels of expression, with values at least five times lower than the second group. The genes with the relative lowest gene expression was ELAM1, the carbohydrate-recognizing protein that has been reported as a marker for glaucomatous trabecular meshwork (71) .
These TaqMan-PCR results further show that, in contrast with the response to pressure, the individual relative abundance of these genes among five genetically different individuals was remarkably similar (Fig. 8) . Only the expression of one gene, the glaucoma-linked myocilin (gene 11 in Fig. 8 ), ranked differently in each individual, a phenomenon that had been suggested earlier based on primary cultured cells (12) . Since the postmortem eyes used here were perfused for over 4 days and most likely medication effects had been washed away from the time of death, the individual variation of this glucocorticoid-responsive gene could not be attributed to the steroid treatment that many donors received prior death.
To investigate whether a similar relative abundance was also observed when using the Affymetrix GeneChips, we analyzed the relative order of the hybridization signals of the same genes in control microarrays of inds. #1, #2, #3, #4, and #5. On the U95Av2 platform (inds. #1 and #2), all ranks were maintained with the exception of MGP, whose available probe set at the time of such chip's manufacture was at gene position 761-1198 (https://www.affymetrix. com/analysis/index.affx) and most likely not optimal. On the U133Plus2.0 platform (inds. #3, #4, and #5), the three groups of genes were maintained but with smaller differ- ences between the first two groups; in ind. #3 myocilin was as high as MGP. In all chips, ELAM1 and ANGPTL7 had very low signals and were classified by the Affymetrix software as Absents.
These results on a random sample of 10 human eyes from different genetic backgrounds and evaluated by two biological procedures (hybridization and amplification) show that, perhaps with the exception of myocilin, the relative abundance of a panel of rationally selected genes is well maintained. This relative abundance represents a molecular signature of the human trabecular meshwork tissue in normal physiological conditions. The data further show that a number of genes normally associated with a significant response to insults and disease, such as ANGPTL7 and ELAM1, do not appear to have the same relevance in normal physiology.
Validation of the four general responder genes identified on the five chips, on two new individuals (inds. #11 and #13).
Because none of the four common genes altered Ͼ1.5-fold had been originally selected for the TaqMan focused arrays, we constant-pressure perfused two eye pairs from two additional individuals and subjected them to the same pressure insult. We measured differential expression of the four identified common genes by TaqMan PCR on the first pair (ind. #11) and assayed the presence and tissue localization of one of their encoded proteins by immunohistochemistry on the second (ind. #13). Taqman results from triplicate samples showed that the four genes were indeed altered by pressure. MMP1 was altered 2.3-fold (2.2/2.4 range), CXCL2 was altered 1.5-fold (1.3/1.6 range), MMP10 was altered 4.2-fold (4.2/4.4 range), and PDPN was altered 3.4-fold (3.1/3.5 range). Fixed cryosections from the HP and CP eyes incubated with a mouse anti-human PDPN antibody showed specific positive reaction on the majority of HP tissue sections, while barely a reaction was observed on the CP sample. The fluorescent signal was localized to the anterior trabecular meshwork, trabecular meshwork, inner wall of the Schlemm's canal, as well as a partial region of the outer wall (Fig. 9) . Together, these results confirm that these four genes are general responders to pressure in all individuals tested.
DISCUSSION
One of the major drawbacks of studying molecular physiological responses in humans has to do with the individual genetic makeup of each individual. This problem is constantly encountered in the assessment and treatment of glaucoma, an eye disease whose major risk factor is the presence of elevated IOP. In the clinic, there is wide variation among absolute IOP values of patients who later develop glaucoma (56) . To address this clinical situation at the molecular level, here we conducted a study to determine how each individual responds to elevated IOP insults. By using the perfusion system with human eyes from postmortem donors and by comparing changes between the two eyes from the same person, our design was not confounded by genetic differences and has the potential of uncovering individual patterns. This is the first study that investigates IOP responses as well as relative abundance of relevant genes in each of the individuals from a random sample of normal human eyes.
Our two approaches, looking for responding genes in the entire transcriptome and examining the response of known, potentially relevant genes, gave us a broader insight. The first offered the opportunity to identify novel genes, and the second allowed us to examine the pressure behavior of the most commonly studied genes in the human trabecular meshwork. Using the microarray approach, we found that some genes that were among the 20 top-changers in one or two individuals were not altered at all in the rest of them. We interpreted this finding, confirmed on the TaqMan focused arrays, as an indication of the existence of genes that are individual responders to pressure. In contrast, we also observed that there were genes that responded to pressure in all, or in all but one individual, which we interpreted as an indication of existence of general responders to pressure. A summary of some selected genes from both groups categorized according to functions relevant to trabecular meshwork physiology is shown in Fig. 10 .
Adhesion/extracellular matrix. We found that genes influencing ECM formation and remodeling occupied an important place in the response to pressure. By examining the function of the genes in this category, we noted that the response to pressure involves a counteracting mechanism. This mechanism would gear the ECM toward a configuration that favors lowering the resistance to aqueous humor outflow. Among these ECM genes, we see MMPs 1, 10, and 12 and the contributors to the formation of elastin network LOX, fibulin 5, and fibrillins 1 and 2. MMP1 influences the collagen network by its activity as an interstitial collagenase, MMP10 (stromelysin 2) degrades proteoglycans and fibronectin (abundant in the trabecular -like meshwork ECM) (20, 74) , and MMP12 is an elastase. Elastin, fibrillin, and fibulins are all key contributors to the formation and upholding of the elastin network, which is believed to be of utmost relevance in the generation of resistance by the trabecular meshwork. LOX is a member of a family of extracellular copper enzymes that are involved in elastogenesis and crosslinking of collagens with elastin, two important components of the trabecular meshwork's ECM. (41) . Formation of the elastin network also requires fibrillin-containing microfibrils, which act as the scaffolds that guide the crosslinking processes. Thickening of elastic fibers and increased elastin have long been shown to be associated with glaucomatous specimens (42) . Another member of the family, LOXL1, binds to fibulin and tropoelastin, and these interactions lead also to the crosslinking process. Interestingly, LOXL1 sequence variants have been recently linked with the development of pseudoexfoliation glaucoma (64), a type of secondary glaucoma characterized by the formation of abnormal microfibrills deposits in the anterior segment of the eye (51). Although both genes, LOX and LOXL1, are located in different chromosomes, their encoded functions are presumably similar and their presence suggests again that what might be relevant for the trabecular meshwork is more the function than the specific gene.
Another relevant ECM gene found was VCAN, a chondroitin sulfate protein that forms proteoglycans and that is associated with elastic-like fibers and microfibrils elements (66) . The amount of chondroitin sulfates is increased in trabecular meshworks from individuals with POAG (37) . Then, we find the ECM gene encoding ANGPTL7, which is of great interest. This gene, whose expression is barely detected under nonstressed conditions, showed up in the most upregulated Affymetrix lists of four individuals, and in all of the TaqMan focused arrays. Actually, in the focused arrays, ANGPTL7 was the only gene that was consistently upregulated, including in ind. #10, where the remaining genes were downregulated. The function of the protein encoded by ANGPTL7, first discovered in the cornea (cornea-derived transcription factor, CDT6) (47), is not yet clear. Our ongoing studies with this gene in human trabecular meshwork cells indicate that its overexpression alters deposition of the ECM and influences levels of relevant ECM components, such as fibronectin. The consequence of pressureinduced ANGPTL7 expression would be in concordance with previously reported inductions of ANGPTL7 by the glaucomatous conditions of DEX and TGF-␤2 and by its proteomic presence in trabecular meshwork of glaucomatous patients (40, 54, 78) .
Calcification. The individual influence of pressure on the inhibitor of calcification gene MGP was mixed. The gene was altered in two out five individuals in the microarrays but altered in all individuals when using the most sensitive TaqMan-PCR technique. We also showed that MGP is a highly abundant gene. This high abundance is perhaps a sign that MGP exists in sufficient levels to protect most individuals and that its regulation by IOP might be conditioned to the regulation of other genes. Thus, it was of interest to find that BMP2, a calcification inducer gene was among the most downregulated genes in three out of five individuals (Fig. 4) . Because MGP inhibits calcification by binding and inhibiting BMP2, these two results together suggest that a high pressure insult would elicit a protective mechanism tending to lower outflow resistance by maintaining the tissue's softness. Other regulated genes with calcification implications, such as CTGF, CALB2, STATH, OGN, and SPARC were also found and could be relevant for the trabecular meshwork. CTGF, which was generally altered by the elevated pressure, is elevated in the aqueous humor of patients with pseudoexfoliation glaucoma (32) . Also regulated in most individuals were CALB2, a vitamin D-dependent calcium-binding protein involved in calcium homeostasis and mineralization (25, 38) , and SPARC, a calcium and collagen binding protein recently proposed to be a collagen chaperone (44) . In contrast, STATH, which regulates calcium-phosphate binding, and OGN were individual responders, suggesting ECM calcification influence only in the individuals where they were altered.
Signaling/cytokines. Our analysis revealed that the category comprising immune-function related and signaling genes appears to have an important role in pressure regulation. We found genes on both the individual and general response groups (Fig. 10) . A good example of these are the finding of the chemokine CXCL2 as one of the four altered genes in all individuals, the presence of four genes encoding inflammatory chemokines on the top 10 most downregulated genes of ind. #2 (Fig. 4) and the downregulation of IL6 in ind. #8 (Fig. 7) . CXCL2, available pharmaceutically under the name garnocestim, is used prior to hematopoietic transformation to reduce cytopenia and his effect on IOP is not known. The role of immunology in glaucoma is just beginning to be addressed (63) . Our observations here could be interpreted to indicate that an elevated pressure could have the ability to modulate the immune response and affect their susceptibility to the disease.
The neuropeptides TAC1 (precursor of substance P), and SCG2 have appeared repeatedly on studies of the trabecular meshwork subjected to mechanical and DEX insults (19, 29, 54) . Our results in Fig. 7 suggest that the expression of these genes appears to be compensatory, that is, to counteract pressure each individual seemed to have the need to express just one of the two genes. These two neuropeptides have been shown to signal an increase in vascular permeability in other tissues, which in the trabecular meshwork could be translated to an increased separation between the Schlemm's canal cells and a facilitation of aqueous humor outflow. Perhaps the proposed function of these genes to signal a potential increase in permeability of the Schlemm's canal is redundant, and both genes could be used indistinctively by different individuals.
Interestingly, we have identified several genes (SFRP4, WIF1, NOV, and to some extent BMP2 and ANGPTL7) (Figs.  3 and 4) , which are known to be modulators of the Wnt signaling pathway. SFRP1, was upregulated in ind #4, who curiously was the only individual where the expression of SFRP4 was not changed. The SFRP1 gene and protein have been reported as increased in trabecular meshwork cells from glaucomatous patients and to be associated with regulation of aqueous humor outflow (72) . The central mediator of the Wnt pathway is ␤-catenin, a protein that controls cell-cell adhesion by its binding to cadherin but that can also acts as a transcriptional regulator for cell proliferation genes (22) . Both functions are critical for trabecular meshwork function. Furthermore, the Wnt pathway is instrumental for the commitment of mesenchymal cell to osteoblasts and bone formation (28) . By microarray analysis, BMP2-induced osteoblast's differentiation markedly upregulated Wnt antagonists SFRP2 and WIF1 (68) . Interestingly, TGF-␤, a growth factor found in the trabecular meshwork of glaucoma patients, upregulates the NOV gene in osteoblasts (17) and several members of the Wnt pathway in the trabecular meshwork (72) . The previously reported presence of a calcification process in the trabecular meshwork (75, 76) causes us to believe that perhaps the Wnt pathway is having the same regulatory mineralization effect in this eye tissue.
Lastly in the signaling category is EDN3, the second most downregulated gene in ind. #4 (found twice). EDN3 is a vasoactive peptide essential for development of neural crestderived cell lineages, which include the trabecular meshwork. Another member of this protein family, endothelin 1, is elevated in the plasma of exfoliation glaucomatous patients (18) and has been long studied as a potential contributor to the pathophysiology of glaucoma (77) .
Stress/defense genes and other individually responder genes. One of the important findings of our study was the identification of genes with a marked individual response. In each of the two approaches, these genes were greatly and very significantly induced just in one of the individuals, and showed no response in the remaining ones. Moreover, when looking at the entire transcriptome, some of the individual responders appeared more than once in the most-altered list, such as transferrin (TF). It also seemed that genes identified in this category could fell into either a protective or detrimental category to the pressure effects. The individuals with upregulated OGN or downregulated CRYAB could be speculated to have an increased risk of deleterious effect due either to an increased calcification (OGN) or to lowering of stress protection (CRYAB). On the other hand, those individuals where IGF1 was upregulated or ELAM1 downregulated could be speculated to be better protected from developing the disease. IGF1, or somatomedin C, is a signaling hormone inducer of a survival pathway whose upregulation could protect the trabecular meshwork cells from cell death. ELAM1 is a secreted glycoprotein that appeared upregulated in all glaucomas and whose downregulation could prevent an individual from developing glaucoma with elevated pressure.
An important number of the genes discussed above are genes that had been known to be relevant for different reasons in the human trabecular meshwork. However, our study did also reveal the presence of novel genes. These would include podoplanin, secreted and transmembrane 1, viperin, GTPbinding Ras-like protein 3, phospholipase A2, aldehyde dehydrogenase 3, phosphoglycerate kinase 1, calbindin and regulator of G protein signaling 5 among the general responders, and DUSP1, statherin, and cadherin 19 among the individual responders. Although these genes are novel, their encoded functions (see Figs. 3 and 4) are representative of mechanisms all known to contribute to the regulation of outflow facility. Interestingly, recent studies have shown that silencing podoplanin in lymphatic endothelial cells impairs RhoA activation, indicating that activation of RhoA is dependent on podoplanin expression (46) . Conversely, we and others have reported the role of RhoA signaling in the regulation of IOP (33, 70) . Treatment of perfused human eye cultures with adenoviruses carrying dominant negative RhoA results in lowering IOP (70) and inhibitors of Rho kinase (ROCK), which is activated by active RhoA, induces a reduction of IOP in rabbits (33) and has a lowering IOP effect in healthy volunteers (62) . It is possible then to consider that a podoplanin increase in the trabecular meshwork with elevated IOP would likely lead to RhoA activation and thus have detrimental consequences for outflow facility. Altogether, these results emphasize the notion that the human trabecular meshwork tissue uses different genes albeit of similar function to attain its global goal of maintenance of proper resistance to aqueous humor outflow. This characteristic could represent an advantage for the use of a variety of pharmacogenetic agents to manage elevated intraocular pressure and protect degeneration of RGC.
In addition, our studies have addressed whether the relative levels of potentially relevant trabecular meshwork genes are maintained in the human trabecular meshwork tissue during physiological pressure conditions. The use of the perfused system, which diminishes the effect of a patient's medications administered at the time of death, showed that the mRNA abundance of the 21 genes studied was very similar. Whether the results obtained with the mRNA translate to protein levels is not yet known.
In summary, by studying IOP response in paired eyes from single postmortem human donors we have uncovered an individual response at the molecular level. We have identified genes whose transcription is altered in most individuals by the elevated IOP insult (general responders), while the expression of others exhibits a strong individual component (individual responders). Although some appear detrimental, more often than not the general responders seemed to encode functions that counteract the deleterious effects of the pressure insult. The individual responders are most likely indicators of a personal susceptibility to the insult due perhaps to undetected differences in transcription factors expression or most likely to individual conformational changes of these proteins triggered by distinct intra-and extracellular environments. These individual environments could be locally influenced by different epidemiology factors, such nutrition or individual stress conditions, and could influence the transcription factor activity. Further understanding of this individual response could lead to a better managing of the control of elevated IOP and glaucoma.]
